January 30, 2019
GP2013 in the Treatment of Patients With Previously Untreated, Advanced Stage Follicular Lymphoma (ASSIST_FL)
Read More
January 30, 2019
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Read More
January 30, 2019
Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer
Read More
January 30, 2019
An Extension Treatment Protocol for Subjects Who Have Participated in a Phase 3 Study of Tivozanib Versus Sorafenib in Renal Cell Carcinoma (Protocol AV-951-09-301)
Read More
January 30, 2019
A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma
Read More
January 30, 2019
ABR-217620/Naptumomab Estafenatox With Interferon-alpha (IFN-alpha) Compared to IFN-alpha Alone in Patients With Advanced Renal Cell Carcinoma
Read More
January 30, 2019
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
Read More
January 30, 2019
Efficacy and Safety Study With MYL-1401H and Neulasta
Read More
January 30, 2019
Neugranin in Breast Cancer Patients Receiving Doxorubicin/Docetaxel (NEUGR-003)
Read More
January 30, 2019
A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone Marrow Involvement
Read More
January 30, 2019
Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV
Read More
January 30, 2019
Phase 2B Dose Ranging Study of Locteron Plus Ribavirin to Treat HCV
Read More
Load More
X